Shares of BillionToOne, Inc. surged 13.02% during intraday trading on Thursday, driven by the company's release of first-quarter financial results that significantly exceeded analyst expectations.
The healthcare company reported Q1 earnings per share of 34 cents, dramatically surpassing the consensus estimate of 4 cents. Revenue for the quarter came in at $108.39 million, also beating the $96.89 million consensus. Furthermore, the company provided optimistic full-year 2026 revenue guidance of $450 million to $465 million, above the consensus estimate of $437.6 million.
Analyst sentiment contributed to the positive momentum, with JP Morgan raising its price target on BillionToOne to $125 from $120. Stifel Nicolaus maintained a Buy rating with a $145 price target, while BTIG maintained its Buy rating, albeit with a reduced price target of $130 from $140. The company's earnings call was described as signaling "profitable hyper-growth," highlighting continued business momentum.
Comments